Succinylation modification: a potential therapeutic target in stroke.

Area of Science:

• Biochemistry
• Neuroscience
• Cell Biology

Background:

• Stroke causes significant global mortality and disability.
• Ischemic cell death, due to reduced oxygen and glucose, is a key stroke pathology.
• Mitochondrial dysfunction and impaired energy metabolism are early events in stroke-induced brain injury.

Purpose of the Study:

• To review the role of lysine succinylation in stroke-related energy metabolism, reactive oxygen species generation, and neuroinflammation.
• To examine Sirtuin 5-mediated desuccinylation in the context of stroke.
• To explore targeting succinylation/desuccinylation as a potential therapeutic strategy for stroke.

Main Methods:

• Literature review focusing on post-translational modifications in stroke.
• Analysis of the regulatory mechanisms of protein succinylation and desuccinylation.
• Examination of Sirtuin 5's role in metabolic enzyme regulation and its implications for stroke.

Main Results:

• Lysine succinylation is a post-translational modification influencing mitochondrial energy metabolism after ischemia.
• Succinylation regulates metabolic pathways by modulating enzyme activity and stability.
• Sirtuin 5, a desuccinylase, plays a critical role in metabolism and is implicated in stroke pathophysiology.
• Imbalance in succinylation/desuccinylation is linked to stroke progression.
• Enhancing Sirtuin 5 activity shows neuroprotective effects in experimental stroke models.

Conclusions:

• Succinylation and desuccinylation dynamics are crucial in stroke-induced metabolic changes.
• Targeting Sirtuin 5 activity presents a promising therapeutic avenue for stroke treatment.
• Further validation is needed to confirm the therapeutic efficacy of Sirtuin 5 activators in human stroke patients.